An Amino-Terminal Truncated Progesterone Receptor Isoform, PRc, Enhances Progestin-Induced Transcriptional Activity

Molecular Endocrinology

Volumn 10, Issue 11, 1996, Pages 1379-1387

  Wei, L L ^a,c   Hawkins, P ^c   Baker, C ^a   Norris, B ^a   Sheridan, P L ^b   Quinn, P G ^c  

^a GEORGETOWN UNIVERSITY   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GESTAGEN; MIFEPRISTONE; PROGESTERONE RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; HELA CELL; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; ENHANCER ELEMENTS (GENETICS); GONANES; HELA CELLS; HORMONE ANTAGONISTS; HUMANS; METHIONINE; MIFEPRISTONE; PROGESTERONE CONGENERS; PROGESTINS; PROMEGESTONE; PROTEIN BIOSYNTHESIS; RECEPTORS, PROGESTERONE; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030460710     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.10.11.8923464     Document Type: Article

References (55)

1. Tsai M-J, O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
2. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
3. Kumar V, Chambon P 1988 The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55:145-156
4. Tsai SY, Duke-Carlstedt J, Weigel NL, Dahlman K, Gustafsson JA, O'Malley BW 1988 Molecular interactions of steroid hormone receptor with its enhancer element: Evidence for receptor dimer formation. Cell 55:361-369
5. Wrange O, Eriksson P, Perlmann T 1989 The purified activated glucocorticoid receptor is a homodimer. J Biol Chem 264:5253-5259
6. Wei LL, Miner RS 1994 Evidence for a third progesterone receptor isoform in human breast cancer cells, T47D. Cancer Res 54:340-343
7. Horwitz KB, Alexander PS 1983 In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation. Endocrinology 113:2195-2201
8. Schrader WT, O'Malley BW 1972 Progesterone-binding components of chick oviducts: characterization of purified subunits. J Biol Chem 247:51-59
9. Conneely OM, Kettelberger DM, Tsai M-J, Schader WT, O'Malley BW 1989 The chicken progesterone receptor A and B isoforms are products of an alternate translation event. J Biol Chem 264:14062-14064
10. Kastner P, Bocquel MT, Turcotte B, Garnier JM, Horwitz KB, Chambon P, Gronemeyer H 1990 Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two isoforms. J Biol Chem 265:12163-12167
11. Krett NL, Wei LL, Francis MD, Nordeen SK, Gordon DF, Wood WM, Horwitz KB 1988 Human progesterone A-receptors can be synthesized intracellularly and are biologically functional. Biochem Biophys Res Commun 157:278-285
12. Schneider W, Ramachandran C, Satyaswaroop PG, Shyamala G 1991 Murine progesterone receptor exists predominantly as the 83-kilodalton 'A' form. J Steroid Biochem Mol Biol 38:285-291
13. Shyamala G, Schneider W, Schott D 1990 Developmental regulation of murine mammary progesterone receptor gene expression. Endocrinology 126:2882-2889
14. Tora L, Gronemeyer H, Turcotte B, Gaub M-P, Chambon P 1988 The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature 333:185-188
15. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP 1993 Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 7:1244-1255
16. Wen DX, Xu Y-F, Mias DE, Godman ME, McDonnell DP 1994 The A and B isoforms of the human progesterone receptor operate though distinct signaling pathways within target cells. Mol Cell Biology 14:8356-8364
17. Tung L, Mohamed JK, Hoeffler JP, Takimoto GS, Horwitz KB 1993 Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol Endocrinol 7:1256-1265
18. Wei LL, Gonzalez-Aller C, Wood WM, Miller LA, Horwitz KB 1990 5′-heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated "C"-receptor and unique A-receptor messages. Mol Endocrinol 4:1833-1840
19. Weigel NL, Beck CA, Estes PA, Prendergast P, Altman M, Christensen K, Edwards DP 1992 Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by site-directed antipeptide monoclonal antibody. Mol Endocrinol 6:1585-1597
20. Foulkes NS, Sassone-Corsi P 1992 More is better: activators and repressors from the same gene. Cell 68:411-414
21. Kozak M 1986 Bifunctional messenger RNAs in eukaryotes. Cell 47:481-483
22. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P 1990 Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9:1603-1614
23. El-Ashy D, Onate SA, Nordeen SK, Edwards DP 1989 Human progesterone receptor complexed with the antagonist RU 486 binds to hormone response elements in a structurally altered form. Mol Endocrinol 3:1545-1558
24. Tasset D, Tora L, Fromental C, Scheer E, Chambon P 1990 Distinct classes of transcriptional activating domains function by different mechanisms. Cell 62:1177-1187
25. Meyer M-E, Gronemeyer H, Turcotte B, Bocquel M-T, Tasset D, Chambon P 1989 Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57:433-442
26. Ptashne M 1988 How eucaryotic transcriptional activators work. Nature 335:683-689
27. Klein-Hitpass L, Cato ACB, Henderson D, Ryffel GU 1991 Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells. Nucleic Acids Res 19:1227-1234
28. Sartorius CA, Groshong SD, Miller LA, Powell RL, Tung L, Takimoto GS, Horwitz KB 1994 New T47D breast cancer cell lines for the independent study of progesterone B-and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res 54:3868-3877
29. Kraus WL, Montano MM, Katzenellenbogen BS 1994 Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene. Mol Endocrinol 8:952-969
30. Fuqua SAW, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW, McGuire WL 1991 Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 51:105-109
31. Ray A, LaForge KS, Sehgal PB 1991 Repressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: is direct DNA binding necessary? Proc Natl Acad Sci USA 88:7086-7090
32. Friend KE, Ang LW, Shupnik MA 1995 Estrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary. Proc Natl Acad Sci USA 92:4367-4371
33. Pace C, Friend KE, Shupnik MA, Transcriptional activation by TERP-1, a naturally occurring rat estrogen receptor variant. 10th International Congress of Endocrinology, San Francisco CA, 1996 (Abstract OR51-7)
34. Seol W, Choi H-S, Moore DD 1996 An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272:1233-1388
35. Forman BM, Umesono K, Chen J, Evans RM 1995 Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541-550
36. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
37. Yang NN, Hardikar S, Kim J, Estrogen receptor regulates the transforming growth factor β3 (TGFβ3) gene expression though a novel mechanism. 77th Annual Meeting of The Endocrine Society, Washington DC, 1995 (Abstract 235)
38. Sheinshedin L, Knauthe R, Sassone-Corsi P, Pornon A, Gronemeyer H 1991 Cell specific inhibitory and stimulatory effects of FOS and JUN on transcription activation by nuclear receptors. EMBO J 10:3839-3849
39. Baniahmad A, Leng S, Burris TP, Tsai SY, Tsai M-J, O'Malley BW 1995 The τ4 activation domain of the thyroid hormone receptor is required to release a corepressor(s) necessary for transcriptional silencing. Mol Cell Biol 15:76-86
40. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
41. Horlein AJ, Naar AM, Heinzel T, Torchia J, Glass B, Kurokawa R, Ryan A, Kamel Y, Soderstrom M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:387-404
42. McDonnell DP, Vegeto E, O'Malley BW 1992 Identification of a negative regulatory function for steroid receptors. Proc Natl Acad Sci USA 89:10563-10567
43. Onate SA, Tsai SY, Tsai M-J, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
44. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M 1994 Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455-1458
45. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG 1995 Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751
46. Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS 1996 Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol 10:119-131
47. Edwards DP, DeMarzo AM, Onate SA, Beck CA, Estes PA, Nordeen SK 1991 Mechanisms controlling steroid receptor binding to specific DNA sequences. Steroids 56:271-278
48. Burnside J, Darling DS, Chin WW 1990 A nuclear factor that enhances binding of thyroid hormone receptors to thyroid hormone receptor elements. J Biol Chem 265:2500-2504
49. Estes PA, Suba EJ, Lawler-Heavner J, Elashy-Stowers D, Wei LL, Toft DO, Sullivan WP, Horwitz KB, Edwards DP 1987 Immunologic analysis of human breast cancer progesterone receptors. I. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies. Biochemistry 26:6250-6262
50. Horwitz KB, Mockus MB, Lessey BA 1982 Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance. Cell 28:633-642
51. Wei LL, Sheridan PL, Krett NL, Francis MD, Toft DO, Edwards DP, Horwitz KB 1987 Immunologic analysis of human cancer progesterone receptors. II. Structural analysis, nuclear phosphorylation and processing. Biochemistry 26:6262-6272
52. Mockus MB, Lessey BA, Bower MA, Horwitz KB 1982 Estrogen-insensitive progesterone receptors in a human breast cancer cell line: characterization of receptors and of ligand exchange assay. Endocrinology 110:1564-1571
53. Chen C, Okayama H 1987 High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752
54. Nordeen SK, Green PP, Fowlkes DM 1987 A rapid, sensitive, and inexpensive assay for chloramphenicol acetyl-transferase. DNA 6:173-178
55. Xing L, Quinn PG 1993 Involvement of 3′,5′-cyclic adenosine monophosphate regulatory element binding protein (CREB) in both basal and hormone-mediated expression of the phosphoenolpyruvate carboxykinase (PEPCK) gene. Mol Endocrinol 7:1484-1494